AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now?
AbbVie still looks like a compelling buy at its all-time high.
Overview
AbbVie (NYSE: ABBV), one of the world's largest pharmaceutical companies, is usually considered a blue chip dividend stock rather than a higher-growth one. Yet over the past five years, its stock has rallied 125% and delivered a total return of 170% with reinvested dividends.
AbbVie has raised its dividend for 53 consecutive years (including its history as part of Abbott Laboratories (NYSE: ABT) up to 2013), putting it in the elite club of Dividend Kings that have boosted their payouts each year for at least half a century. It also still looks like a bargain at 18 times forward earnings. So is AbbVie one of the best healthcare stocks to buy right now?
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.